Then, patients were stratified into two groups: prostate cancer with a known genomic alteration vs. unknown, and the co-expression analysis showed that three lncRNAs: lnc-SNX10-87, lnc-AP1S2-2 and ADPGK-AS1 have significant correlation values with other coding genes. The gene discussed is AP1S2; the disease is prostate carcinoma.